Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis.

Fu X, Meng Z, Liang W, Tian Y, Wang X, Han W, Lou G, Wang X, Lou F, Yen Y, Yu H, Jove R, Huang W.

Oncogene. 2014 Aug 21;33(34):4296-306. doi: 10.1038/onc.2013.385. Epub 2013 Sep 23.

2.

miR-203 enhances let-7 biogenesis by targeting LIN28B to suppress tumor growth in lung cancer.

Zhou Y, Liang H, Liao Z, Wang Y, Hu X, Chen X, Xu L, Hu Z.

Sci Rep. 2017 Feb 20;7:42680. doi: 10.1038/srep42680.

3.

MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells.

Dang X, Ma A, Yang L, Hu H, Zhu B, Shang D, Chen T, Luo Y.

Cancer Genet. 2012 Mar;205(3):113-23. doi: 10.1016/j.cancergen.2012.01.002.

PMID:
22469510
4.

MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.

Krutilina R, Sun W, Sethuraman A, Brown M, Seagroves TN, Pfeffer LM, Ignatova T, Fan M.

Breast Cancer Res. 2014 Jul 28;16(4):R78. doi: 10.1186/bcr3693.

5.

miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.

Thomsen KG, Terp MG, Lund RR, Søkilde R, Elias D, Bak M, Litman T, Beck HC, Lyng MB, Ditzel HJ.

Oncotarget. 2015 Oct 6;6(30):29224-39. doi: 10.18632/oncotarget.4942.

6.

MiR-26a enhances invasive capacity by suppressing GSK3β in human lung cancer cells.

Lin G, Liu B, Meng Z, Liu Y, Li X, Wu X, Zhou Q, Xu K.

Exp Cell Res. 2017 Mar 15;352(2):364-374. doi: 10.1016/j.yexcr.2017.02.033. Epub 2017 Feb 21.

PMID:
28237093
7.

miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.

Si Y, Zhang H, Ning T, Bai M, Wang Y, Yang H, Wang X, Li J, Ying G, Ba Y.

Cell Physiol Biochem. 2017;42(4):1670-1683. doi: 10.1159/000479412. Epub 2017 Jul 24.

8.

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY.

Cell Res. 2008 Mar;18(3):350-9. doi: 10.1038/cr.2008.24.

9.

MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.

Kato M, Goto Y, Matsushita R, Kurozumi A, Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M, Ichikawa T, Seki N.

Int J Oncol. 2015 Aug;47(2):710-8. doi: 10.3892/ijo.2015.3043. Epub 2015 Jun 10.

PMID:
26063484
10.

MicroRNA-26a involved in Toll-like receptor 9‑mediated lung cancer growth and migration.

Jiang DS, Wang YW, Jiang J, Li SM, Liang SZ, Fang HY.

Int J Mol Med. 2014 Jul;34(1):307-12. doi: 10.3892/ijmm.2014.1764. Epub 2014 Apr 30.

PMID:
24788552
11.

miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.

Liang H, Liu S, Chen Y, Bai X, Liu L, Dong Y, Hu M, Su X, Chen Y, Huangfu L, Li X, Gu Y, Shan H.

J Mol Med (Berl). 2016 Jun;94(6):655-65. doi: 10.1007/s00109-016-1381-8. Epub 2016 Jan 20.

PMID:
26787543
12.

Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.

Yao L, Han C, Song K, Zhang J, Lim K, Wu T.

Cancer Res. 2015 Apr 1;75(7):1388-98. doi: 10.1158/0008-5472.CAN-14-2561. Epub 2015 Feb 17.

13.

miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.

Lv M, Zhang X, Li M, Chen Q, Ye M, Liang W, Ding L, Cai H, Fu D, Lv Z.

PLoS One. 2013 Jul 5;8(7):e67591. doi: 10.1371/journal.pone.0067591. Print 2013.

14.

MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.

Lu J, Song G, Tang Q, Yin J, Zou C, Zhao Z, Xie X, Xu H, Huang G, Wang J, Lee DF, Khokha R, Yang H, Shen J.

Oncogene. 2017 Jan 12;36(2):231-241. doi: 10.1038/onc.2016.194. Epub 2016 Jun 6.

PMID:
27270422
15.

Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.

Koh CM, Iwata T, Zheng Q, Bethel C, Yegnasubramanian S, De Marzo AM.

Oncotarget. 2011 Sep;2(9):669-83.

16.

MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.

Liu B, Wu X, Liu B, Wang C, Liu Y, Zhou Q, Xu K.

Biochim Biophys Acta. 2012 Nov;1822(11):1692-704. doi: 10.1016/j.bbadis.2012.07.019. Epub 2012 Aug 4.

17.

MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).

Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB.

Oncogene. 2011 Jun 9;30(23):2644-58. doi: 10.1038/onc.2010.642. Epub 2011 Feb 28.

PMID:
21358675
18.

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.

Png KJ, Halberg N, Yoshida M, Tavazoie SF.

Nature. 2011 Dec 14;481(7380):190-4. doi: 10.1038/nature10661.

PMID:
22170610
19.

Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.

Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Perilli L, Rossi E, Esposito G, Rugge M, Pilati P, Mocellin S, Nitti D, Bortoluzzi S, Zanovello P.

BMC Genomics. 2013 Aug 29;14:589. doi: 10.1186/1471-2164-14-589.

20.

MiR-26a inhibits prostate cancer progression by repression of Wnt5a.

Zhao S, Ye X, Xiao L, Lian X, Feng Y, Li F, Li L.

Tumour Biol. 2014 Oct;35(10):9725-33. doi: 10.1007/s13277-014-2206-4. Epub 2014 Jun 28.

PMID:
24972966

Supplemental Content

Support Center